Infectious Diseases
Penicillin Allergy Record is a Fossil for Many Adults
Ongoing study demonstrates majority flagged can safely receive penicillin.
Platelets Act as First Responders to COVID-19 and Flu
Heart attack and stroke risks rise as cells respond to respiratory infections.
New Technique Uncovers Antibodies for Viral Pathogens
High-throughput approach reveals ultrapotent candidate with efficacy against SARS-CoV-2 variants.
Lessons Learned on Tobacco During the Pandemic
Pattern shifts could inform future evidence-based addiction interventions.
COVID-19 Antibody Treatment AZD7442 Developed in Record Time
Extensive experience enabled treatment’s development in well under one month.
Holistic Support for COVID-19 Long-haulers
Providers share best means of helping survivors recover from trauma, cognitive injury.
Large-scale Data Emerges on COVID-19 Hospitalizations
Head of Vanderbilt-led study discusses ongoing research to evaluate SARS-CoV-2 vaccines.
Respiratory Microbiome May Impact COVID-19 Severity
New study will detail role of upper respiratory tract bacteria in susceptibility to SARS-CoV-2.
Facing Down COVID-19 at Every Level
From drug discovery to health equity, Vanderbilt joins worldwide leaders to conquer the pandemic.
Urinary E. coli : Harmless or Harmful?
Downloadable dataset catalogues clinical isolates by morphology and symptomatology.
Population-based Study Connects Diet and Gut Flora
Prospective, longitudinal data from a population-based study offer insights on flora diversity and species.